Overview
David Mechlin is an Otolaryngologist in Columbia, Missouri. Dr. Mechlin is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), and Empyema. Dr. Mechlin is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Mechlin isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Mechlin isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- Experienced
- Allergic RhinitisDr. Mechlin isExperienced. Learn about Allergic Rhinitis.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
- DFNB1Dr. Mechlin isExperienced. Learn about DFNB1.
- EmpyemaDr. Mechlin isExperienced. Learn about Empyema.
- Infant Hearing LossDr. Mechlin isExperienced. Learn about Infant Hearing Loss.
- Jones SyndromeDr. Mechlin isExperienced. Learn about Jones Syndrome.